Role of TOLL-like receptors in adjuvant-augmented immune therapies by T. Seya

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 1, 2006, Pages 133-137

  Cooper, Edwin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CD24 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 12; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; THY 1 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; CYTOKINE PRODUCTION; EVIDENCE BASED MEDICINE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 33745698796     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nek020     Document Type: Note

References (53)

1. Tsujita T, Tsukada H, Nakao M, Oshiumi H, Matsumoto M, Seya T. Sensing bacterial flagellin by membrane and soluble orthologs of TOLL-like receptor 5 in rainbow trout (Onchorhynchus mikiss). J Biol Chem 2004;279:48588-97.
2. Seya T, Akazawa T, Tsujita T, Matsumoto M. Role of TOLL-like receptors in adjuvant-augmented immune therapies. Evid Based Complement Alternat Med 2006;3:31-38.
3. Yoon YD, Han SB, Kang JS, Lee CW, Park SK, Lee HS, et al. TOLL-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum. Int Immunopharmacol 2003;3:1873-82.
4. Kasai H, He LM, Kawamura M, Yang PT, Deng XW, Munkanta M, et al. IL-12 production induced by Agaricus blazei fraction H (ABH) involves TOLL-like receptor (TLR). Evid Based Complement Alternat Med 2004;1:259-67.
5. Ventura C. CAM and cell fate targeting: molecular and energetic insights into cell growth and differentiation. Evid Based Complement Alternat Med 2005;2:277-83.
6. Itoh H, Ito H, Amano H, Noda H. Inhibitory action of action of a (1-6)-β-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ('Himematsutake') on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol 1994;66:265-71.
7. Osaki Y, Kato T, Yamamoto K, Okubo J, Miyazaki T. Antimutagenic and bactericidal substances in fruit body of a basidiomycete Agaricus blazei. Yakugaku Zasshi 1994;114:342-50.
8. Fujimiya Y, Suzuki Y, Oshiman K, Kobori H, Moriguchi K, Nakashima H, et al. Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunol Immunother 1998;46:147-59.
9. Fujimiya Y, Suzuki Y, Katakura R, Ebina T. Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete Agaricus blazei Murill. Anticancer Res 1999;19:113-8.
10. Takaku T, Kimura Y, Okuda H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 2001;131:1409-13.
11. Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Itoh H, et al. Fractionation an antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res 1989;186:267-73.
12. Ito H, Shimura K, Itoh H, Kawade M. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepare from Agaricus blazei (Iwade Strain 101) 'Himematsutake' and its mechanisms in tumor-bearing mice. Anticancer Res 1997;17:277-84.
13. Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotech Biochem 1998;63:434-7.
14. Mizuno T, Hagiwara T, Nakamura T, Ito H, Shimura K, Sumiya T, Asakura A. Studies on the host-medicated antitumor polysaccharides. Part XIII. Antitumor activity and some properties of water-soluble polysaccharides from Himematsutake, the fruiting body of Agaricus blazei Murill. Agric Biol Chem 1990;54:2889-96.
15. Kawagishi H, Katsumi R, Sazawa T, Mizuno T, Hagiwara T, Nakamura T. Cytotoxic steroid from the mashroom Agaricus blazei. Photochemistry 1988;27:2777-9.
16. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and TOLL-like receptor 2. J Exp Med 2003;197:1107-17.
17. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003;197:1119-24.
18. Yoon YD, Han SB, Kang JS, Lee CW, Park SK, Lee HS, et al. TOLL-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix Platycodon grandiflorum. Int Immunopharmacol 2003;3:1873-82.
19. Christophides GK, Zdobnov E, Barillas-Mury C, Birney E, Blandin S, Blass C, et al. Immunity-related genes and gene families in Anopheles gambiae. Science 2002;278:159-65.
20. Flajnik MF, DuPasquier L. Evolution of innate and adaptive immunity: can we draw a line?. Trends Immunol 2004;25:640-4.
21. Agaisse H, Perrimon N. The roles of JAK/STAT signalling in Drosophila immune responses. Immunol Rev 2004;198:72-82.
22. Kim DH, Ausubel FM. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans. Curr Opin Immunol 2005;17:4-10.
23. Engelmann P, Cooper EL, Németh P. Review anticipating innate immunity without a TOLL. Mol Immunol 2005;42:931-42.
24. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manely JL, et al. Structural basis for signal transduction by the TOLL/interleukin-1 receptor domains. Nature 2000;408:111-5.
25. Horng T, Medzhitov R. Drosophila MyD88 is an adapter in the TOLL signaling pathway. Proc Natl Acad Sci USA 2001;98:12654-8.
26. Kocsis B, Emody L. Pathogen-associated molecular pattern of bacteria and its recognition by the host. Hum Immunol 2003;2:10-9.
27. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from TOLL-like receptors. Science 2004;304:1014-8.
28. Pasare C, Medzhitov R. TOLL-like receptors and acquired immunity. Semin Immunol 2004;16:23-6.
29. Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, et al. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 2004;5:488-94.
30. Cooper EL, Kauschke E, Cossarizza A. Digging for innate immunity since Darwin and Metchnikoff. Bioessays 2002;24:319-33.
31. Beschin A, Bilej M, Hanssens F, Raymakers J, Van Dyck E, Revets H, et al. Identification and cloning of a glucan- and lipopolysaccharide-binding protein from Eisenia foetida earthworm involved in the activation of prophenoloxidase cascade. J Biol Chem 1998;273:24948-54.
32. Paramvir D, Satou Y, Campbell RK, Chapman J, Degnan B, De Tomaso A, et al. The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science 2002;298:2157-67.
33. Azumi K, De Santis R, De Tomaso A, Rigoutsos I, Yoshizaki F, Pinto MR, et al. Genomic analysis of immunity in a urochordate and the emergence of the vertebrate immune system: 'waiting for Godot'. Immunogenetics 2003;55:570-81.
34. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol 2002;3:1150-5.
35. Cooper EL. Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura. Evid Based Complement Alternat Med 2004;1:29-34.
36. Medzhitov R, Janeway C Jr. The TOLL receptor family and microbial recognition. Trends Microbiol 2000;10:452-6.
37. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the TOLL-like receptors and their transducers. J Leukoc Biol 2003;74:479-85.
38. Takeda T, Okumura K. CAM and NK cells. Evid Based Complement Alternat Med 2004;1:17-27.
39. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-6.
40. Takeda K, Kaisho T, Akira S. TOLL-like receptors. Annu Rev Immunol 2003;21:335-76.
41. Akira S, Takeda K, Kaisho T. TOLL-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-80.
42. Yeh WC, Chen NJ. Another TOLL road. Nature 2003;424:736-7.
43. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adopter molecule that participates in TOLL-like receptor 3-mediated interferon-b induction. Nat Immunol 2003;4:161-7.
44. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, et al. The TOLL-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999;401:811-5.
45. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and TOLL-like receptor 2. J Exp Med 2003;197:1107-17.
46. Kaminogawa S, Nanno M. Modulation of immune functions by foods. Evid Based Complement Alternat Med 2004;1:241-50.
47. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Different TOLL-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos. J Immunol 2003;171:4984-9.
48. Yoon YD, Kang JS, Han SB, Park SK, Lee HS, Kang JS, Kim HM. Activation of mitogen-activated protein kinases and AP-1 by polysaccharide isolated from the radix of Platycodon grandiflorum in RAW 264.7 cells. Int Immunopharmacol 2004;12:1477-87.
49. Okamoto M, Oh-E G, Oshikawa T, Furuichi S, Tano T, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Himeno K, Sato M, Ohkubo S. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Clin Diagn Lab Immunol 2004;11:483-95.
50. Han SB, Yoon YD, Ahn HJ, Lee HS, Lee CW, Yoon WK, Park SK, Kim HM. Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus. Int Immunopharmacol 2003;3:1301-12.
51. Lee KY, Jeon YJ. Polysaccharide isolated from Poria cocos sclerotium induces NF-kappaB/Rel activation and iNOS expression in murine macrophages. Int Immunopharmacol 2003;3:1353-62.
52. Han SB, Park SH, Lee KH, Lee CW, Lee SH, Kim HC, Kim YS, Lee HS, Kim HM. Polysaccharide isolated from the radix of Platycodon grandiflorum selectively activates B cells and macrophages but not T cells. Int Immunopharmacol 2001;1:1969-78.
53. Cooper EL. CAM, eCAM, Bioprospecting. The 21st Century Pyramid. Evid Based Complement Alternat Med 2005;2:125-7.